Talk:Tilidine
| This is the talk page for discussing improvements to the Tilidine article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: |
||||||||||
| |||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tilidine.
|
Stronger analogs
Nortilidine made a brief appearent were mentioned in 'Drugs Forum' in 2012. I was interested in the isomerism of the compound and discovered US Patent 4921059 where the 'reversed ester' of the secondary amine shows the action clearly. The N-methyl overlays cypenamine perfectly which re-enforces the stimulant and opioid action. — Preceding unsigned comment added by Dvwynn (talk • contribs) 13:12, 11 June 2014 (UTC)
Legal status in Germany
atm, the article states that tilidine is listed on Anlage II and, therefore, is prohibited. As a matter of fact, it is listed on Anlage III as well, which makes it marketable and prescribable "except in preparations which, without another substance from annexes I to III, contain up to 7 per cent or up to 300 mg of tilidine per dosage unit, calculated as a base, and, in relation to these quantities, at least 7.5 per cent of naloxone hydrochloride" http://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/Gesetze_und_Verordnungen/GuV/A/AnnexIII_marketable_and_prescribable_narcotic_drugs_072010.pdf An explanation would be too much text for the infobox, I guess; but in its current state it is just wrong. --קеלея 13:20, 28 November 2016 (UTC)